Filing Details
- Accession Number:
- 0000899243-20-008616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-17 16:38:45
- Reporting Period:
- 2020-03-16
- Accepted Time:
- 2020-03-17 16:38:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1341235 | Aldeyra Therapeutics Inc. | ALDX | Biological Products, (No Disgnostic Substances) (2836) | MA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021015 | Richard Douglas | C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-16 | 40,000 | $2.75 | 125,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
